PERSPECTA

News from every angle

Back to headlines

BioAge Labs Reports Q4 GAAP EPS of -$2.24, Beats Revenue Estimates

BioAge Labs announced its Q4 GAAP EPS of -$2.24, surpassing analyst estimates by $0.08, and reported revenue of $8.99 million, beating expectations by $1.88 million.

24 Mar, 20:32 — 24 Mar, 20:32
PostShare

Sources

Showing 1 of 1 sources